SEMAGLUTIDE 10 mg

Semaglutide 10 mg — GLP-1 Receptor Agonist for Metabolic Research

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor
agonist studied extensively in preclinical and clinical research for its effects on
glycemic control, body weight, appetite regulation, and cardiometabolic markers.
It is a synthetic analog of human GLP-1 with amino-acid substitutions and a fatty-acid side chain
to extend half-life via albumin binding.

What It Is

• Class: GLP-1 receptor agonist (incretin mimetic)
• Concept: Designed to mimic and prolong native GLP-1 signaling involved
  in glucose-dependent insulin secretion and appetite regulation.
• Format: Research-grade synthetic peptide supplied as a lyophilized powder.

Proposed Mechanisms (Preclinical)

Selected Research Highlights

• Type 2 Diabetes Models: Semaglutide has been studied for improvements in
  fasting glucose, HbA1c, and post-prandial glycemic control in preclinical and clinical
  diabetes research.
• Obesity & Weight Management: Trials and models report meaningful
  weight loss and appetite reduction with GLP-1 receptor agonism, including
  changes in caloric intake and food preference.
• Cardiovascular Risk: GLP-1 RAs such as semaglutide have been investigated
  for effects on major adverse cardiovascular events (MACE), blood pressure, and lipid profiles.
• Liver & NAFLD/NASH: Ongoing research explores impacts on liver fat,
  transaminases, and nonalcoholic fatty-liver disease–related endpoints.

Chemical & Handling Information

• Type: Synthetic GLP-1 analog (long-acting)
• Backbone: Modified human GLP-1 peptide with fatty-acid side chain for
  albumin binding and prolonged half-life (exact modification per specification/lot)
• Appearance: White to off-white lyophilized powder

Specifications

• Peptide: Semaglutide
• Amount: 10 mg per vial
• Form: Lyophilized powder
• Purity: ?99% (HPLC); COA per lot available
• Packaging: Sealed vials suitable for standard laboratory handling

Storage & Stability

• Store lyophilized vials in a cool, dry place, protected from light.
• Refrigeration or freezing of the lyophilized peptide is recommended for extended stability,
  according to laboratory SOPs.
• After reconstitution, store at 2–8 °C for short-term use.
• For long-term storage, aliquot and freeze at ?20 °C or below; avoid repeated freeze–thaw cycles.